Properties of the amniotic membrane may be applicable in cancer therapy

Jae Hong Seo1, Yeul Hong Kim, Jun Suk Kim

  • 1Department of Medical Oncology, Medical College, Korea University, Seoul, Republic of Korea.

Medical Hypotheses
|October 2, 2007
PubMed

The amniotic membrane secretes various substances and has many functions, such as antiangiogenic activity, immunoregulatory activity, pro-apoptotic activity, antimicrobial properties, antifibroblastic activity, cell migration, and cell growth-promoting activity. Of these functions, we mainly focus on antiangiogenic activity, immunoregulatory activity, and pro-apoptotic activity and their applications in tumor biology. The amniotic membrane provides a privileged space anatomically, physiologically, and immunologically to the fetus. Angiogenesis occurs in tumor growth, and destruction of the immunologic barrier is an inevitable process in tumor invasion and metastasis. Regarding tumor cell killing, the pro-apoptotic pathway should be activated. Therefore, if we could apply the characteristics of the amniotic membrane to tumor biology, we might encounter a breakthrough in cancer treatment. For example, if a tumor mass could be enclosed by the amniotic membrane surgically, the growth of the tumor might be retarded. Further experiments and clinical trials should be conducted to verify our hypotheses.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...